Seguir
Chakravarthi Balabhadrapatruni
Chakravarthi Balabhadrapatruni
Scientific Investigator
Dirección de correo verificada de gsk.com - Página principal
Título
Citado por
Citado por
Año
UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses
DS Chandrashekar, B Bashel, SAH Balasubramanya, CJ Creighton, ...
Neoplasia 19 (8), 649-658, 2017
47542017
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ...
Nature medicine 22 (3), 298-305, 2016
14222016
Genomic and epigenomic alterations in cancer
BVSK Chakravarthi, S Nepal, S Varambally
The American journal of pathology 186 (7), 1724-1735, 2016
1882016
Production of paclitaxel by Fusarium solani isolated from Taxus celebica
B Chakravarthi, P Das, K Surendranath, AA Karande, C Jayabaskaran
Journal of biosciences 33, 259-267, 2008
1522008
Ferrocene-Conjugated l-Tryptophan Copper(II) Complexes of Phenanthroline Bases Showing DNA Photocleavage Activity and Cytotoxicity
TK Goswami, BVSK Chakravarthi, M Roy, AA Karande, AR Chakravarty
Inorganic chemistry 50 (17), 8452-8464, 2011
1442011
Development of peptidomimetic inhibitors of the ERG gene fusion product in prostate cancer
X Wang, Y Qiao, IA Asangani, B Ateeq, A Poliakov, M Cieślik, S Pitchiaya, ...
Cancer cell 31 (4), 532-548. e7, 2017
1132017
Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer
MT Goswami, G Chen, BVSK Chakravarthi, SS Pathi, SK Anand, ...
Oncotarget 6 (27), 23445, 2015
1022015
The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression
BVSK Chakravarthi, SS Pathi, MT Goswami, M Cieślik, H Zheng, ...
Oncotarget 5 (16), 6654, 2014
942014
Role of transcriptional corepressor CtBP1 in prostate cancer progression
R Wang, IA Asangani, BVSK Chakravarthi, B Ateeq, RJ Lonigro, Q Cao, ...
Neoplasia 14 (10), 905-IN8, 2012
832012
MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer
BVSK Chakravarthi, MT Goswami, SS Pathi, AD Robinson, M Cieślik, ...
Oncogene 35 (49), 6330-6340, 2016
642016
miR-34a regulates expression of the stathmin-1 oncoprotein and prostate cancer progression
BVSK Chakravarthi, DS Chandrashekar, S Agarwal, ...
Molecular Cancer Research 16 (7), 1125-1137, 2018
572018
A role for de novo purine metabolic enzyme PAICS in bladder cancer progression
BVSK Chakravarthi, MDCR Pena, S Agarwal, DS Chandrashekar, ...
Neoplasia 20 (9), 894-904, 2018
522018
Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancer
BVSK Chakravarthi, MT Goswami, SS Pathi, M Dodson, ...
The Prostate 77 (1), 10-21, 2017
502017
Impact of metal binding on the antitumor activity and cellular imaging of a metal chelator cationic imidazopyridine derivative
M Roy, BVSK Chakravarthi, C Jayabaskaran, AA Karande, ...
Dalton Transactions 40 (18), 4855-4864, 2011
462011
Inhibition of cancer cell proliferation and apoptosis-inducing activity of fungal taxol and its precursor baccatin III purified from endophytic Fusarium solani
BVSK Chakravarthi, R Sujay, GC Kuriakose, AA Karande, ...
Cancer Cell International 13, 1-11, 2013
422013
PAICS, a purine nucleotide metabolic enzyme, is involved in tumor growth and the metastasis of colorectal cancer
S Agarwal, BVSK Chakravarthi, M Behring, HG Kim, DS Chandrashekar, ...
Cancers 12 (4), 772, 2020
372020
Targeting P4HA1 with a small molecule inhibitor in a colorectal cancer PDX model
S Agarwal, M Behring, HG Kim, P Bajpai, BVSK Chakravarthi, N Gupta, ...
Translational oncology 13 (4), 100754, 2020
352020
TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status
S Agarwal, M Behring, HG Kim, DS Chandrashekar, BVSK Chakravarthi, ...
Molecular oncology 14 (12), 3007-3029, 2020
282020
PAICS, a de novo purine biosynthetic enzyme, is overexpressed in pancreatic cancer and is involved in its progression
S Agarwal, BVSK Chakravarthi, HG Kim, N Gupta, K Hale, ...
Translational Oncology 13 (7), 100776, 2020
242020
Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression
DS Chandrashekar, BVSK Chakravarthi, AD Robinson, JC Anderson, ...
Oncogene 39 (20), 4077-4091, 2020
242020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20